Case Report Nondysraphic Thoracic Intradural Intramedullary Lipoma in A 35-Year-Old Female
by Kamal Deep Khatri, Sushil Acharya, Gograj Garhwal, Kushal Goyal*
Department of Neurosurgery, JLN Medical College, India
*Corresponding author: Kushal Goyal, MCh Resident, Department of Neurosurgery, JLN Medical College, Ajmer, Rajasthan, India.
Received Date: February 24, 2026
Accepted Date: March 05, 2026
Published Date: March 09, 2026
Citation: Khatri KD, Acharya S, Garhwal G, Goyal K (2026) Nondysraphic Thoracic Intradural Intramedullary Lipoma in A 35-Year-Old Female. J Neurol Exp Neural Sci 8:174. DOI: https://doi.org/10.29011/2577-1442.100174
Abstract
Background: Nondysraphic intramedullary lipomas (NILs) are exceptionally rare, representing a minute fraction of primary spinal cord lesions that occur within an intact spinal column, often clinically mimicking more common myelopathies. Case Description: We present the case of a 35-year-old patient exhibiting subacute neurological decline. Diagnostic imaging confirmed a fatty intramedullary mass. Management involved microsurgical decompression and subtotal resection, prioritizing the preservation of neural integrity over radical excision. Outcomes: Postoperatively, the patient showed immediate stabilization of neurological deficits. At the six-month follow-up, significant improvement in motor strength and sensory function was observed, with no evidence of symptomatic tumor regrowth on serial imaging. Conclusion: Success in Nondysraphic intramedullary lipoma management hinges on recognizing the "liponeural interface." Because the absence of a proper distinct surgical plane carries a high risk of iatrogenic injury, a conservative operative strategy focused on decompression rather than gross total resection remains the gold standard for favorable long-term outcomes.
Keywords: Nondysraphic; Intramedullary; Lipoma; Spinal cord; Microsurgery
© by the Authors & Gavin Publishers. This is an Open Access Journal Article Published Under Attribution-Share Alike CC BY-SA: Creative Commons Attribution-Share Alike 4.0 International License. Read More About Open Access Policy.